<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01801878</url>
  </required_header>
  <id_info>
    <org_study_id>B-1206-158-005</org_study_id>
    <secondary_id>06-2012-193</secondary_id>
    <nct_id>NCT01801878</nct_id>
  </id_info>
  <brief_title>Pilot Study of Skin Quality Improvement After Adipose-drived Stem Cell Transfer in Irradiated Breasts</brief_title>
  <official_title>Pilot Study of Skin Quality Improvement After Adipose-drived Stem Cell Transfer in Irradiated Breasts</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the skin quality of using adipose-drived stromal&#xD;
      vascular fraction (SVF) cell taken by automatic centrifuge for adipose-drived cell isolation&#xD;
      system into irradiated breasts.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      10 participants who taken conservative mastectomy will be enrolled&#xD;
&#xD;
        1. Process&#xD;
&#xD;
             -  adipose tissue is obtained from the subject's thigh or abdomen&#xD;
&#xD;
             -  adipose-drived stromal vascular fraction(SVF)cell isolation using automatic&#xD;
                centrifuge system&#xD;
&#xD;
             -  adipose-drived stromal vascular fraction(SVF)cell graft into the irradiated breast.&#xD;
&#xD;
        2. Duration of study&#xD;
&#xD;
             -  entire duration: approximate 30weeks&#xD;
&#xD;
             -  Follow-up period: 12 weeks&#xD;
&#xD;
             -  Enrollment period: 12 weeks&#xD;
&#xD;
        3. Study design - Randomized, prospective, pilot study&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Difficulty in recruiting research subjects&#xD;
  </why_stopped>
  <start_date type="Anticipated">December 1, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The change in the breast skin thickness of the pre and post SVF graft from baseline at 12week after procedure</measure>
    <time_frame>change in the breast skin thickness from baseline at 12 week</time_frame>
    <description>The efficacy is assessed by breast skin thickness measured by radiologist using breast ultrasonography</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Breast Neoplasms</condition>
  <condition>Skin Abnormalities</condition>
  <arm_group>
    <arm_group_label>Adipose SVF cell</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>adipose SVF cell transfer to the half of irradiated breast</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Normal saline inject to the half of irradiated breast</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Adipose SVF cell</intervention_name>
    <description>adipose SVF cell transfer to the half of irradiated breast</description>
    <arm_group_label>Adipose SVF cell</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>Normal saline inject to the half of irradiated breast</description>
    <arm_group_label>Normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female aged between 40 and 60&#xD;
&#xD;
          -  Subjects who diagnosed breast ductal carcinoma in situ of surgical staging T1aN0,&#xD;
             negative resection margin of below 2mm in histopathologic examination&#xD;
&#xD;
          -  Subjects who have a relapse-free interval of more than one year after&#xD;
             breast-conserving surgery for breast cancer and radiation therapy&#xD;
&#xD;
          -  Subjects who understand the study contents and sign the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects who have radiodermatitis&#xD;
&#xD;
          -  Subjects who planned breast reconstruction with autogenous tissue (ex.Transverse&#xD;
             Rectus Abdominis Muscle flap)&#xD;
&#xD;
          -  Subjects who have a history of smoking within 3months recently&#xD;
&#xD;
          -  Subjects who participated in other clinical trial within 30 days recently&#xD;
&#xD;
          -  Pregnant or lactating subjects&#xD;
&#xD;
          -  Subjects who have a active infectious disease&#xD;
&#xD;
          -  Subjects who are not eligible for this study at the discretion of the investigator&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chanyeong Heo, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National Univ. Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Bundang,Gyeonggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>February 27, 2013</study_first_submitted>
  <study_first_submitted_qc>February 28, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 1, 2013</study_first_posted>
  <last_update_submitted>October 21, 2020</last_update_submitted>
  <last_update_submitted_qc>October 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>breast cancer</keyword>
  <keyword>loss of elasticity in irradiated breast skin</keyword>
  <keyword>Other Reconstructive Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Skin Abnormalities</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

